BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30851097)

  • 1. Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
    Joly F; Ahmed-Lecheheb D; Kalbacher E; Heutte N; Clarisse B; Grellard JM; Gernier F; Berton-Rigaud D; Tredan O; Fabbro M; Savoye AM; Kurtz JE; Alexandre J; Follana P; Delecroix V; Dohollou N; Roemer-Becuwe C; De Rauglaudre G; Lortholary A; Prulhiere K; Lesoin A; Zannetti A; N'Guyen S; Trager-Maury S; Chauvenet L; Abadie Lacourtoisie S; Gompel A; Lhommé C; Floquet A; Pautier P
    Ann Oncol; 2019 May; 30(5):845-852. PubMed ID: 30851097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.
    Gernier F; Gompel A; Rousset-Jablonski C; Kalbacher E; Floquet A; Berton-Rigaud D; Tredan O; Alexandre J; Follana P; Zannetti A; Dohollou N; Grellard JM; Clarisse B; Licaj I; Ahmed-Lecheheb D; Fauvet R; Pautier P; Joly F
    Gynecol Oncol; 2021 Dec; 163(3):598-604. PubMed ID: 34649724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".
    Gernier F; Ahmed-Lecheheb D; Pautier P; Floquet A; Nadeau C; Frank S; Alexandre J; Selle F; Berton-Rigaud D; Kalbacher E; Orfeuvre H; Lortholary A; Augereau P; Labombarda F; Perrier L; Grellard JM; Licaj I; Clarisse B; Savoye AM; Bourien H; De La Motte Rouge T; Kurtz JE; Kerdja K; Lelaidier A; Charreton A; Ray-Coquard I; Joly F
    BMC Cancer; 2021 Oct; 21(1):1147. PubMed ID: 34702204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis.
    Clevenger L; Schrepf A; Degeest K; Bender D; Goodheart M; Ahmed A; Dahmoush L; Penedo F; Lucci J; Thaker PH; Mendez L; Sood AK; Slavich GM; Lutgendorf SK
    Cancer; 2013 Sep; 119(17):3234-41. PubMed ID: 23797955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls.
    Gultekin SC; Cakir AB; Guc ZG; Ozalp FR; Keskinkilic M; Yavuzsen T; Yavuzsen HT; Karadibak D
    Support Care Cancer; 2024 Jan; 32(2):119. PubMed ID: 38252310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported distress in patients with ovarian cancer: is it related to disease status?
    Ploos van Amstel FK; van Ham MA; Peters EJ; Prins JB; Ottevanger PB
    Int J Gynecol Cancer; 2015 Feb; 25(2):229-35. PubMed ID: 25594140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.
    Webber K; Carolus E; Mileshkin L; Sommeijer D; McAlpine J; Bladgen S; Coleman RL; Herzog TJ; Sehouli J; Nasser S; Inci G; Friedlander M
    Gynecol Oncol; 2019 Oct; 155(1):126-134. PubMed ID: 31416612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?
    Liavaag AH; Dørum A; Fosså SD; Tropé C; Dahl AA
    J Clin Oncol; 2007 May; 25(15):2049-56. PubMed ID: 17513809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fatigue and fatigability correlates in Korean breast cancer survivors and differences in associations with anxiety, depression, sleep disturbance, and endocrine symptoms: a randomized controlled trial.
    Jang MK; Han J; Kim SH; Ko YH; Kim SY; Kim S
    BMC Cancer; 2021 Jul; 21(1):855. PubMed ID: 34311713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach.
    Lutgendorf SK; Shinn E; Carter J; Leighton S; Baggerly K; Guindani M; Fellman B; Matzo M; Slavich GM; Goodman MT; Tew W; Lester J; Moore KM; Karlan BY; Levine DA; Sood AK
    Gynecol Oncol; 2017 Jul; 146(1):101-108. PubMed ID: 28527672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of symptoms described by ovarian cancer survivors.
    Stavraka C; Ford A; Ghaem-Maghami S; Crook T; Agarwal R; Gabra H; Blagden S
    Gynecol Oncol; 2012 Apr; 125(1):59-64. PubMed ID: 22155797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
    Osann K; Wenzel L; McKinney C; Wagner L; Cella D; Fulci G; Scroggins MJ; Lankes HA; Wang V; Nephew KP; Maxwell GL; Mok SC; Conrads TP; Miller A; Birrer M
    Gynecol Oncol; 2023 Apr; 171():151-158. PubMed ID: 36905875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and active disease are the major risk factors for fatigue and sleep disturbance in inflammatory bowel disease with consequent poor quality of life: Analysis of the interplay between psychosocial factors from the developing world.
    Pal P; Banerjee R; Vijayalaxmi P; Reddy DN; Tandan M
    Indian J Gastroenterol; 2024 Feb; 43(1):226-236. PubMed ID: 37851205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cancer stage on health-related quality of life of patients with epithelial ovarian cancer.
    Techata A; Muangmool T; Wongpakaran N; Charoenkwan K
    J Obstet Gynaecol; 2022 Jan; 42(1):139-145. PubMed ID: 33938358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis.
    Götze H; Friedrich M; Taubenheim S; Dietz A; Lordick F; Mehnert A
    Support Care Cancer; 2020 Jan; 28(1):211-220. PubMed ID: 31001695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.
    Brown AJ; Sun CC; Urbauer DL; Bodurka DC; Thaker PH; Ramondetta LM
    Gynecol Oncol; 2015 Aug; 138(2):388-93. PubMed ID: 25988961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of EEG biofeedback on reducing postcancer cognitive impairment.
    Alvarez J; Meyer FL; Granoff DL; Lundy A
    Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.
    Schmidt ME; Chang-Claude J; Vrieling A; Heinz J; Flesch-Janys D; Steindorf K
    J Cancer Surviv; 2012 Mar; 6(1):11-9. PubMed ID: 22160661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of quality of life in ovarian cancer survivors: a pilot study.
    Teng FF; Kalloger SE; Brotto L; McAlpine JN
    J Obstet Gynaecol Can; 2014 Aug; 36(8):708-715. PubMed ID: 25222166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry.
    Husson O; Nieuwlaat WA; Oranje WA; Haak HR; van de Poll-Franse LV; Mols F
    Thyroid; 2013 Oct; 23(10):1247-55. PubMed ID: 23578315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.